Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study All patients were seen by one of the investigators at Columbia University, and patients who received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback